These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24713302)

  • 1. Botulinum neurotoxin A subtype 2 reduces pathological behaviors more effectively than subtype 1 in a rat Parkinson's disease model.
    Itakura M; Kohda T; Kubo T; Semi Y; Azuma YT; Nakajima H; Kozaki S; Takeuchi T
    Biochem Biophys Res Commun; 2014 May; 447(2):311-4. PubMed ID: 24713302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum neurotoxin type A subtype 2 confers greater safety than subtype 1 in a rat Parkinson's disease model.
    Itakura M; Kohda T; Kubo T; Semi Y; Nishiyama K; Azuma YT; Nakajima H; Kozaki S; Takeuchi T
    J Vet Med Sci; 2014 Aug; 76(8):1189-93. PubMed ID: 24849052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and structural effects of unilateral intrastriatal injections of botulinum neurotoxin a in the rat model of Parkinson's disease.
    Antipova V; Hawlitschka A; Mix E; Schmitt O; Dräger D; Benecke R; Wree A
    J Neurosci Res; 2013 Jun; 91(6):838-47. PubMed ID: 23553727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson's disease.
    Wree A; Mix E; Hawlitschka A; Antipova V; Witt M; Schmitt O; Benecke R
    Neurobiol Dis; 2011 Feb; 41(2):291-8. PubMed ID: 20955797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated intrastriatal application of botulinum neurotoxin-A did not influence choline acetyltransferase-immunoreactive interneurons in hemiparkinsonian rat brain - A histological, stereological and correlational analysis.
    Hawlitschka A; Berg C; Schmitt O; Holzmann C; Wree A; Antipova V
    Brain Res; 2020 Sep; 1742():146877. PubMed ID: 32387181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intrastriatal botulinum neurotoxin A on the behavior of Wistar rats.
    Holzmann C; Dräger D; Mix E; Hawlitschka A; Antipova V; Benecke R; Wree A
    Behav Brain Res; 2012 Sep; 234(1):107-16. PubMed ID: 22728288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrastriatal injection of botulinum neurotoxin-A is not cytotoxic in rat brain - A histological and stereological analysis.
    Mehlan J; Brosig H; Schmitt O; Mix E; Wree A; Hawlitschka A
    Brain Res; 2016 Jan; 1630():18-24. PubMed ID: 26562665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's disease.
    Tsuboi K; Shults CW
    Exp Neurol; 2002 Jan; 173(1):95-104. PubMed ID: 11771942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.
    Antipova V; Holzmann C; Hawlitschka A; Witt M; Wree A
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [
    Mann T; Kurth J; Hawlitschka A; Stenzel J; Lindner T; Polei S; Hohn A; Krause BJ; Wree A
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29509680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6.
    Moritz MS; Tepp WH; Bradshaw M; Johnson EA; Pellett S
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.
    Zanetti G; Sikorra S; Rummel A; Krez N; Duregotti E; Negro S; Henke T; Rossetto O; Binz T; Pirazzini M
    PLoS Pathog; 2017 Aug; 13(8):e1006567. PubMed ID: 28800600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson's Disease Differently Affects Behavior.
    Antipova VA; Holzmann C; Schmitt O; Wree A; Hawlitschka A
    Front Behav Neurosci; 2017; 11():119. PubMed ID: 28680396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25.
    Lawrence GW; Ovsepian SV; Wang J; Aoki KR; Dolly JO
    Neuropharmacology; 2013 Jul; 70():287-95. PubMed ID: 23485402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin.
    Egevad G; Petkova VY; Vilholm OJ
    J Parkinsons Dis; 2014; 4(3):321-6. PubMed ID: 24919823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Intrastriatal Applications of Botulinum Neurotoxin-A: A Review.
    Hawlitschka A; Wree A
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29735936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrastriatally injected botulinum neurotoxin-A differently effects cholinergic and dopaminergic fibers in C57BL/6 mice.
    Hawlitschka A; Holzmann C; Witt S; Spiewok J; Neumann AM; Schmitt O; Wree A; Antipova V
    Brain Res; 2017 Dec; 1676():46-56. PubMed ID: 28919466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated Intrastriatal Botulinum Neurotoxin-A Injection in Hemiparkinsonian Rats Increased the Beneficial Effect on Rotational Behavior.
    Hawlitschka A; Holzmann C; Wree A; Antipova V
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA.
    Dominguez-Meijide A; Villar-Cheda B; Garrido-Gil P; Sierrra-Paredes G; Guerra MJ; Labandeira-Garcia JL
    Neuropharmacology; 2014 Jan; 76 Pt A():156-68. PubMed ID: 23973568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1.
    Pier CL; Chen C; Tepp WH; Lin G; Janda KD; Barbieri JT; Pellett S; Johnson EA
    FEBS Lett; 2011 Jan; 585(1):199-206. PubMed ID: 21126520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.